Search Results - "Basson, Bruce"

Refine Results
  1. 1
  2. 2

    Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial by Vincent, Jean-Louis, Angus, Derek C, Artigas, Antonio, Kalil, Andre, Basson, Bruce R, Jamal, Hassan H, Johnson, Gerald, Bernard, Gordon R

    Published in Critical care medicine (01-03-2003)
    “…OBJECTIVETo assess morbidity in patients with severe sepsis managed with and without drotrecogin alfa (activated). DESIGNAnalysis of secondary end points in a…”
    Get full text
    Journal Article
  3. 3

    Long-term olanzapine treatment : Weight change and weight-related health factors in schizophrenia by KINON, Bruce J, BASSON, Bruce R, GILMORE, Julie A, TOLLEFSON, Gary D

    Published in The journal of clinical psychiatry (01-02-2001)
    “…Weight change and the weight-related health factors of nonfasting serum glucose, serum cholesterol, and diastolic blood pressure levels were analyzed in…”
    Get full text
    Journal Article
  4. 4

    Survival advantage associated with heterozygous factor V Leiden mutation in patients with severe sepsis and in mouse endotoxemia by Kerlin, Bryce A., Yan, S. Betty, Isermann, Berend H., Brandt, John T., Sood, Rashmi, Basson, Bruce R., Joyce, David E., Weiler, Hartmut, Dhainaut, Jean-Francois

    Published in Blood (01-11-2003)
    “…Sepsis is associated with systemic inflammation, coagulopathy, and disrupted protein C (PC) pathway function. The effect of prothrombotic polymorphism, factor…”
    Get full text
    Journal Article
  5. 5

    Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis by Angus, Derek C, Linde-Zwirble, Walter T, Clermont, Gilles, Ball, Daniel E, Basson, Bruce R, Ely, E Wesley, Laterre, Pierre-Francois, Vincent, Jean-Louis, Bernard, Gordon, van Hout, Ben

    Published in Critical care medicine (01-01-2003)
    “…OBJECTIVETo assess the cost-effectiveness of drotrecogin alfa (activated) therapy, which was recently shown to reduce mortality in severe sepsis…”
    Get full text
    Journal Article
  6. 6

    Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone by BASSON, Bruce R, KINON, Bruce J, TAYLOR, Cindy C, SZYMANSKI, Keith A, GILMORE, Julie A, TOLLEFSON, Gary D

    Published in The journal of clinical psychiatry (01-04-2001)
    “…Clinical factors predicting weight change in patients with schizophrenia and related disorders during acute treatment with the antipsychotic drugs olanzapine,…”
    Get full text
    Journal Article
  7. 7
  8. 8

    The Effect of Raloxifene after Discontinuation of Long-Term Alendronate Treatment of Postmenopausal Osteoporosis by Michalská, Dana, Stepan, Jan J., Basson, Bruce R., Pavo, Imre

    “…Objective: The aim of this study was to compare bone mineral density (BMD) and biochemical markers of bone turnover in patients receiving long-term alendronate…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Antipsychotic treatment and sexual functioning in first-time neuroleptic-treated schizophrenic patients by Bitter, István, Basson, Bruce R, Dossenbach, Martin R

    Published in International clinical psychopharmacology (01-01-2005)
    “…The present study examined sexual functioning among first-time treated schizophrenia patients at the time that they initiated antipsychotic treatment, and…”
    Get full text
    Journal Article
  11. 11

    Efficacy and Treatment Satisfaction with On-Demand Tadalafil (Cialis ®) in Men with Erectile Dysfunction by Skoumal, René, Chen, Juza, Kula, Krzysztof, Breza, Jan, Calomfirescu, Nicolae, Basson, Bruce R, Kopernicky, Vladimir

    Published in European urology (01-09-2004)
    “…Objective: Tadalafil (Cialis ®) is an inhibitor of phosphodiesterase type 5, which mediates relaxation of vascular smooth muscle in the corpus cavernosum thus…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Strategies for switching from conventional antipsychotic drugs or risperidone to olanzapine by KINON, Bruce J, BASSON, Bruce R, GILMORE, Julie A, MALCOLM, Sandra, STAUFFER, Virginia L

    Published in The journal of clinical psychiatry (01-11-2000)
    “…This study compared the efficacy and safety of 4 therapeutically relevant strategies for switching clinically stable patients from a conventional antipsychotic…”
    Get full text
    Journal Article
  15. 15
  16. 16

    The Comparative Peripheral Anticholinergic-Like Adverse Event Profiles of Olanzapine and Risperidone by Kennedy, John S., Bymaster, Frank P., Basson, Bruce R., Gilmore, Julie A., Tran, Pierre V.

    “…OBJECTIVE: To test the hypothesis that reported in vitro muscarinic receptor affinity differences between olanzapine and risperidone would be reflected in…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20